SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-059139
Filing Date
2022-09-27
Accepted
2022-09-27 08:00:34
Documents
4
Period of Report
2022-09-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea166372-6k_chinasxt.htm 6-K 26186
2 FORM OF VOTING AGREEMENT, DATED SEPTEMBER 22, 2022, BY AND BETWEEN ZHIJUN XIAO A ea166372ex4-1_chinasxt.htm EX-4.1 50271
3 FORM OF VOTING AGREEMENT, DATED SEPTEMBER 22, 2022, BY AND BETWEEN ZHIJUN XIAO A ea166372ex4-2_chinasxt.htm EX-4.2 48139
4 FORM OF SPA, DATED SEPTEMBER 22, 2022, BY AND BETWEEN THE COMPANY AND ZHIJUN XIA ea166372ex10-1_chinasxt.htm EX-10.1 330623
  Complete submission text file 0001213900-22-059139.txt   456205
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 221267286
SIC: 2834 Pharmaceutical Preparations